Avid Radiopharmaceuticals and Lighthouse Capital Partners Harvard Case Solution & Analysis

In autumn 2008 the company lender to decide whether to give the credit to Avid, a small but promising venture capital, life sciences companies. When considering its proposal, Christie Barnes considers characteristics of the company and how they differ from conventional investments. At the same time, CEO and venture capitalist learn the true costs and benefits of taking credit, especially in the uncertain economic climate of the time. "Hide
by Matthew Rhodes-Kropf, Ann Leamon Source: Harvard Business School 15 pages. Publication Date: September 23, 2009. Prod. #: 810054-PDF-ENG

Share This

SALE SALE

Save Up To

30%

IN ONLINE CASE STUDY

FOR FREE CASES AND PROJECTS INCLUDING EXCITING DEALS PLEASE REGISTER YOURSELF !!

Register now and save up to 30%.